Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2025-12-12
• Last 15 days FTD volume: A$0.12 M
• Last 3 months FTD volume: A$4.99 M
• Last 12 months FTD volume: A$10.48 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Ultragenyx Pharmaceutical RARE	A$1.09 M	A$6.98 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$7.77 M	A$14.33 M	🇺🇸 USA
Pfizer PFE	A$27.68 M	A$0.10 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	A$4.41 M	A$72.51 M	🇺🇸 USA
Amicus Therapeutics FOLD	A$8.41 M	A$14.56 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	A$0.6 M	A$12.04 M	🇺🇸 USA